This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
antibody
product name :
Human VEGFR2/KDR/Flk-1 PE-conjugated Antibody
catalog :
FAB357P
quantity :
25 Tests
price :
119 USD
clonality :
monoclonal
host :
mouse
conjugate :
PE
clone name :
89106
reactivity :
human
application :
flow cytometry
citations: 90
Published Application/Species/Sample/DilutionReference
  • flow cytometry; human; fig st1
Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
Thom C, Jobaliya C, Lorenz K, Maguire J, Gagne A, Gadue P, et al. Tropomyosin 1 genetically constrains in vitro hematopoiesis. BMC Biol. 2020;18:52 pubmed publisher
Jo E, Wu S, Han H, Park J, Park S, Cho K. Effects of exergaming in postmenopausal women with high cardiovascular risk: A randomized controlled trial. Clin Cardiol. 2020;43:363-370 pubmed publisher
Liang J, Li Y, Chen L, Xia W, Wu G, Tong X, et al. Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension: a substudy of EXCAVATION-CHN1. J Transl Med. 2019;17:368 pubmed publisher
Sabbah N, Tamari T, Elimelech R, Doppelt O, Rudich U, Zigdon Giladi H. Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels. Biomolecules. 2019;9: pubmed publisher
Mair B, Tomic J, Masud S, Tonge P, Weiss A, Usaj M, et al. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Rep. 2019;27:599-615.e12 pubmed publisher
Masuda S, Matsuura K, Shimizu T. Preparation of iPS cell-derived CD31+ endothelial cells using three-dimensional suspension culture. Regen Ther. 2018;9:1-9 pubmed publisher
Ahmed F, Bakhashab S, Bastaman I, Crossland R, Glanville M, Weaver J. Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study. Int J Mol Sci. 2018;19: pubmed publisher
Bassetti B, Carbucicchio C, Catto V, Gambini E, Rurali E, Bestetti A, et al. Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO). Stem Cell Res Ther. 2018;9:235 pubmed publisher
Ensari I, Burg M, Diaz K, Fu J, Duran A, Suls J, et al. Putative mechanisms Underlying Myocardial infarction onset and Emotions (PUME): a randomised controlled study protocol. BMJ Open. 2018;8:e020525 pubmed publisher
Tanaka R, Masuda H, Fujimura S, Ito Hirano R, Arita K, Kakinuma Y, et al. Quality-Quantity Control Culture Enhances Vasculogenesis and Wound Healing Efficacy of Human Diabetic Peripheral Blood CD34+ Cells. Stem Cells Transl Med. 2018;7:428-438 pubmed publisher
Jia H, Thelwell C, Dilger P, Bird C, Daniels S, Wadhwa M. Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy. Thromb Res. 2018;163:105-116 pubmed publisher
Maroun Eid C, Ortega Hernández A, Modrego J, Abad Cardiel M, García Donaire J, Reinares L, et al. Effect of intensive multifactorial treatment on vascular progenitor cells in hypertensive patients. PLoS ONE. 2018;13:e0190494 pubmed publisher
Lodola F, Laforenza U, Cattaneo F, Ruffinatti F, Poletto V, Massa M, et al. VEGF-induced intracellular Ca2+ oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells. Oncotarget. 2017;8:95223-95246 pubmed publisher
Topel M, Hayek S, Ko Y, Sandesara P, Samman Tahhan A, Hesaroieh I, et al. Sex Differences in Circulating Progenitor Cells. J Am Heart Assoc. 2017;6: pubmed publisher
Jinesh G, Kamat A. The Blebbishield Emergency Program Overrides Chromosomal Instability and Phagocytosis Checkpoints in Cancer Stem Cells. Cancer Res. 2017;77:6144-6156 pubmed publisher
Ke X, Zou J, Hu Q, Wang X, Hu C, Yang R, et al. Hydrogen Sulfide-Preconditioning of Human Endothelial Progenitor Cells Transplantation Improves Re-Endothelialization in Nude Mice with Carotid Artery Injury. Cell Physiol Biochem. 2017;43:308-319 pubmed publisher
Palpant N, Wang Y, Hadland B, Zaunbrecher R, Redd M, Jones D, et al. Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis. Cell Rep. 2017;20:1597-1608 pubmed publisher
Li Y, Brauer P, Singh J, Xhiku S, Yoganathan K, Zuniga Pflucker J, et al. Targeted Disruption of TCF12 Reveals HEB as Essential in Human Mesodermal Specification and Hematopoiesis. Stem Cell Reports. 2017;9:779-795 pubmed publisher
Spigoni V, Aldigeri R, Antonini M, Micheli M, Fantuzzi F, Fratter A, et al. Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study. Int J Mol Sci. 2017;18: pubmed publisher
Bittencourt C, Izar M, França C, Schwerz V, Póvoa R, Fonseca F. Effects of Chronic Exercise on Endothelial Progenitor Cells and Microparticles in Professional Runners. Arq Bras Cardiol. 2017;108:212-216 pubmed publisher
Guo P, Yang J, Bielenberg D, Dillon D, Zurakowski D, Moses M, et al. A quantitative method for screening and identifying molecular targets for nanomedicine. J Control Release. 2017;263:57-67 pubmed publisher
Benyamine A, Magalon J, Cointe S, Lacroix R, Arnaud L, Bardin N, et al. Increased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis. Arthritis Res Ther. 2017;19:60 pubmed publisher
Lopez P, Rodríguez Carrio J, Martínez Zapico A, Caminal Montero L, Suarez A. Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity. Int J Cardiol. 2017;236:138-144 pubmed publisher
Dei Cas A, Spigoni V, Cito M, Aldigeri R, Ridolfi V, Marchesi E, et al. Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes. Cardiovasc Diabetol. 2017;16:27 pubmed publisher
Huang L, Couto J, Pinto A, Alexandrescu S, Madsen J, Greene A, et al. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome. Pediatr Neurol. 2017;67:59-63 pubmed publisher
Tournois C, Pignon B, Sevestre M, Al Rifai R, Creuza V, Poitevin G, et al. Cell therapy in critical limb ischemia: A comprehensive analysis of two cell therapy products. Cytotherapy. 2017;19:299-310 pubmed publisher
Xia W, Chen L, Liang J, Zhang X, Su C, Tong X, et al. BMP4/Id2 signaling pathway is a novel therapeutic target for late outgrowth endothelial progenitor cell-mediated endothelial injury repair. Int J Cardiol. 2017;228:796-804 pubmed publisher
Chou C, Jiang S, Pan H, Yen Y, Tseng H, Hung Y, et al. Endothelial cell colony forming units derived from malignant breast diseases are resistant to tumor necrosis factor-?-induced apoptosis. Sci Rep. 2016;6:37450 pubmed publisher
Polena H, Boudou F, Tilleul S, Dubois Colas N, Lecointe C, Rakotosamimanana N, et al. Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination. Sci Rep. 2016;6:33162 pubmed publisher
Reischauer S, Stone O, Villasenor A, Chi N, Jin S, Martin M, et al. Cloche is a bHLH-PAS transcription factor that drives haemato-vascular specification. Nature. 2016;535:294-8 pubmed publisher
Takahashi K, Satoh M, Takahashi Y, Osaki T, Nasu T, Tamada M, et al. Dysregulation of ossification-related miRNAs in circulating osteogenic progenitor cells obtained from patients with aortic stenosis. Clin Sci (Lond). 2016;130:1115-24 pubmed publisher
Wang H, Su S, Wang Y, Chang S, Liao K, Lo H, et al. MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared Irradiation. PLoS ONE. 2016;11:e0147067 pubmed publisher
West D, Campbell M, Gonzalez J, Walker M, Stevenson E, Ahmed F, et al. The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study. Cardiovasc Diabetol. 2015;14:71 pubmed publisher
Craft A, Rockel J, Nartiss Y, Kandel R, Alman B, Keller G. Generation of articular chondrocytes from human pluripotent stem cells. Nat Biotechnol. 2015;33:638-45 pubmed publisher
Gori J, Butler J, Chan Y, Chandrasekaran D, Poulos M, Ginsberg M, et al. Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells. J Clin Invest. 2015;125:1243-54 pubmed publisher
Wang T, Xiao M, Ge Y, Krepler C, Belser E, Lopez Coral A, et al. BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth. Clin Cancer Res. 2015;21:1652-64 pubmed publisher
To C, Farnsworth R, Vail M, Chheang C, Gargett C, Murone C, et al. Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth. PLoS ONE. 2014;9:e112106 pubmed publisher
Huang L, Nakayama H, Klagsbrun M, Mulliken J, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells. 2015;33:133-45 pubmed publisher
Van t Hull E, Bron S, Henry L, Ifticene Treboux A, Turrini R, Coukos G, et al. Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer. Oncoimmunology. 2014;3:e29080 pubmed
Stamati K, Priestley J, Mudera V, Cheema U. Laminin promotes vascular network formation in 3D in vitro collagen scaffolds by regulating VEGF uptake. Exp Cell Res. 2014;327:68-77 pubmed publisher
Kraan J, van den Broek P, Verhoef C, Grunhagen D, Taal W, Gratama J, et al. Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells. Br J Cancer. 2014;111:149-56 pubmed publisher
Poncina N, Albiero M, Menegazzo L, Cappellari R, Avogaro A, Fadini G. The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients. Cardiovasc Diabetol. 2014;13:92 pubmed publisher
Orlova V, van den Hil F, Petrus Reurer S, Drabsch Y, Ten Dijke P, Mummery C. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat Protoc. 2014;9:1514-31 pubmed publisher
Hernandez S, Gong J, Chen L, Wu I, Sun J, Keenan H, et al. Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes. Diabetes Care. 2014;37:2193-201 pubmed publisher
Chan K, Simpson P, Yong A, Dunn L, Chawantanpipat C, Hsu C, et al. The relationship between endothelial progenitor cell populations and epicardial and microvascular coronary disease-a cellular, angiographic and physiologic study. PLoS ONE. 2014;9:e93980 pubmed publisher
Zucco L, Zhang Q, Kuliszewski M, Kandic I, Faughnan M, Stewart D, et al. Circulating angiogenic cell dysfunction in patients with hereditary hemorrhagic telangiectasia. PLoS ONE. 2014;9:e89927 pubmed publisher
Spinetti G, Specchia C, Fortunato O, Sangalli E, Clerici G, Caminiti M, et al. Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia. Diabetes Care. 2014;37:1410-7 pubmed publisher
Graziani F, Leone A, Basile E, Cialdella P, Tritarelli A, Bona R, et al. Endothelial progenitor cells in morbid obesity. Circ J. 2014;78:977-85 pubmed
Mirkina I, Hadzijusufovic E, Krepler C, Mikula M, Mechtcheriakova D, Strommer S, et al. Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R. PLoS ONE. 2014;9:e84417 pubmed publisher
Rodríguez Carrio J, de Paz B, López P, Prado C, Alperi López M, Ballina García F, et al. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients. PLoS ONE. 2014;9:e86069 pubmed publisher
Grimaldi A, Balestrieri M, D Onofrio N, Di Domenico G, Nocera C, Lamberti M, et al. The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrence. PLoS ONE. 2013;8:e79658 pubmed publisher
Qi Y, Jiang Q, Chen C, Cao Y, Qian L. Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide. PLoS ONE. 2013;8:e79060 pubmed publisher
Veréb Z, Lumi X, Andjelic S, Globocnik Petrovic M, Urbancic M, Hawlina M, et al. Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy. Biomed Res Int. 2013;2013:492376 pubmed publisher
Orlova V, Drabsch Y, Freund C, Petrus Reurer S, van den Hil F, Muenthaisong S, et al. Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts. Arterioscler Thromb Vasc Biol. 2014;34:177-86 pubmed publisher
Bueno Betí C, Novella S, Lázaro Franco M, Pérez Cremades D, Heras M, Sanchis J, et al. An affordable method to obtain cultured endothelial cells from peripheral blood. J Cell Mol Med. 2013;17:1475-83 pubmed publisher
den Dekker W, Houtgraaf J, Rowland S, Ligtenberg E, de Boer S, de Jong R, et al. Efficiency of statin treatment on EPC recruitment depends on baseline EPC titer and does not improve angiographic outcome in coronary artery disease patients treated with the Genous stent. Cell Transplant. 2014;23:1525-35 pubmed publisher
Pelosi E, Castelli G, Martin Padura I, Bordoni V, Santoro S, Conigliaro A, et al. Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endothelium. PLoS ONE. 2012;7:e51109 pubmed publisher
Shantsila E, Tapp L, Wrigley B, Montoro García S, Lip G. CXCR4 positive and angiogenic monocytes in myocardial infarction. Thromb Haemost. 2013;109:255-62 pubmed publisher
Fadini G, Albiero M, Vigili de Kreutzenberg S, Boscaro E, Cappellari R, Marescotti M, et al. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care. 2013;36:943-9 pubmed publisher
Albert R, Veréb Z, Csomós K, Moe M, Johnsen E, Olstad O, et al. Cultivation and characterization of cornea limbal epithelial stem cells on lens capsule in animal material-free medium. PLoS ONE. 2012;7:e47187 pubmed publisher
Fekete N, Rojewski M, Furst D, Kreja L, Ignatius A, Dausend J, et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE. 2012;7:e43255 pubmed publisher
Ahrens I, Domeij H, Topcic D, Haviv I, Merivirta R, Agrotis A, et al. Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression. PLoS ONE. 2011;6:e23210 pubmed publisher
Narazaki M, Segarra M, Hou X, Tanaka T, Li X, Tosato G. Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood. 2010;116:3099-107 pubmed publisher
Churdchomjan W, Kheolamai P, Manochantr S, Tapanadechopone P, Tantrawatpan C, U Pratya Y, et al. Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control. BMC Endocr Disord. 2010;10:5 pubmed publisher
Nilsson M, Zage P, Zeng L, Xu L, Cascone T, Wu H, et al. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene. 2010;29:2938-49 pubmed publisher
Ball S, Bayley C, Shuttleworth C, Kielty C. Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells. Biochem J. 2010;427:29-40 pubmed publisher
Suzuki H, Onishi H, Wada J, Yamasaki A, Tanaka H, Nakano K, et al. VEGFR2 is selectively expressed by FOXP3high CD4+ Treg. Eur J Immunol. 2010;40:197-203 pubmed publisher
Lee D, Cho T, Lee H, Park M, Yoo W, Chung C, et al. Distraction osteogenesis induces endothelial progenitor cell mobilization without inflammatory response in man. Bone. 2010;46:673-9 pubmed publisher
Saulle E, Riccioni R, Coppola S, Parolini I, Diverio D, Riti V, et al. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation. Br J Haematol. 2009;145:399-411 pubmed publisher
Westerweel P, Visseren F, Hajer G, Olijhoek J, Hoefer I, de Bree P, et al. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur Heart J. 2008;29:2808-17 pubmed publisher
Saeki K, Yogiashi Y, Nakahara M, Nakamura N, Matsuyama S, Koyanagi A, et al. Highly efficient and feeder-free production of subculturable vascular endothelial cells from primate embryonic stem cells. J Cell Physiol. 2008;217:261-80 pubmed publisher
Thill M, Strunnikova N, Berna M, Gordiyenko N, Schmid K, Cousins S, et al. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:2696-708 pubmed publisher
Fernandez L, Rodriguez S, Huang H, Chora A, Fernandes J, Mumaw C, et al. Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol. 2008;36:545-558 pubmed publisher
Yang L, Soonpaa M, Adler E, Roepke T, Kattman S, Kennedy M, et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008;453:524-8 pubmed publisher
Meissner M, Pinter A, Michailidou D, Hrgovic I, Kaprolat N, Stein M, et al. Microtubule-targeted drugs inhibit VEGF receptor-2 expression by both transcriptional and post-transcriptional mechanisms. J Invest Dermatol. 2008;128:2084-91 pubmed publisher
Narazaki M, Segarra M, Tosato G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood. 2008;111:4126-36 pubmed publisher
Kern J, Bauer M, Rychli K, Wojta J, Ritsch A, Gastl G, et al. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation. Arterioscler Thromb Vasc Biol. 2008;28:478-84 pubmed publisher
Zhang P, Li J, Tan Z, Wang C, Liu T, Chen L, et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells. Blood. 2008;111:1933-41 pubmed
Lee P, Li Y, Richards H, Chan F, Zhuang H, Narain S, et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 2007;56:3759-69 pubmed
Shawber C, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell S, et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest. 2007;117:3369-82 pubmed
Vroling L, Yuana Y, Schuurhuis G, van Hinsbergh V, Gundy C, de Haas R, et al. VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients. Thromb Haemost. 2007;98:440-50 pubmed
Rafat N, Hanusch C, Brinkkoetter P, Schulte J, Brade J, Zijlstra J, et al. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit Care Med. 2007;35:1677-84 pubmed
Norden Zfoni A, Desai J, Manola J, Beaudry P, Force J, Maki R, et al. Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin Cancer Res. 2007;13:2643-50 pubmed
Ball S, Shuttleworth C, Kielty C. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol. 2007;177:489-500 pubmed
Porat Y, Porozov S, Belkin D, Shimoni D, Fisher Y, Belleli A, et al. Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages. Br J Haematol. 2006;135:703-14 pubmed
Wang C, Verma S, Hsieh I, Chen Y, Kuo L, Yang N, et al. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol. 2006;41:34-43 pubmed
Narazaki M, Tosato G. Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood. 2006;107:3892-901 pubmed
Danet G, Pan Y, Luongo J, Bonnet D, Simon M. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest. 2003;112:126-35 pubmed
Pigott R, Needham L, Edwards R, Walker C, Power C. Structural and functional studies of the endothelial activation antigen endothelial leucocyte adhesion molecule-1 using a panel of monoclonal antibodies. J Immunol. 1991;147:130-5 pubmed
product information
brand :
R&D Systems
master code :
FAB357P
SKU :
FAB357P-025
product name :
Human VEGFR2/KDR/Flk-1 PE-conjugated Antibody
description :
The Human VEGFR2/KDR/Flk-1 PE-conjugated Antibody from R&D Systems is a mouse monoclonal antibody to VEGFR2/KDR/Flk-1. This antibody reacts with human. The Human VEGFR2/KDR/Flk-1 PE-conjugated Antibody has been validated for the following applications: Flow Cytometry.
target :
VEGFR2/KDR/Flk-1
category :
Primary Antibodies
unit size :
25 Tests
buffer :
Supplied in a saline solution containing BSA and Sodium Azide.
clonality :
Monoclonal
clone :
89106
conjugate :
Phycoerythrin
host :
Mouse
immunogen :
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human VEGF R2/KDR/Flk-1, Ala20-Glu764, Accession # P35968
isotype :
IgG1
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Human
specificity :
Detects human VEGF R2/KDR/Flk-1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) VEGF R1, rhVEGF R3 or recombinant mouse VEGF R2 is observed.
gene symbol :
KDR
catalog number base :
FAB357P
accessionNumbers :
P35968
applications :
Flow Cytometry
2020 USD :
119
2021 USD :
119 USD
alt names :
CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-2
storage :
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.